Richard R Drake Selected Research

2- N- (6'- (1'- pyridinium)hexanoyl)sphingosine

1/2013

LCL124, a cationic analog of ceramide, selectively induces pancreatic cancer cell death by accumulating in mitochondria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard R Drake Research Topics

Disease

45	Neoplasms (Cancer) 01/2022 - 11/2002
23	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 10/2006
11	Breast Neoplasms (Breast Cancer) 01/2021 - 05/2004
5	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 03/2005
4	Fibrosis (Cirrhosis) 01/2022 - 03/2005
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2013
3	Nephritis 02/2022 - 06/2015
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 10/2018
3	Neoplasm Metastasis (Metastasis) 01/2021 - 06/2011
3	Aortic Valve Stenosis (Aortic Stenosis) 01/2021 - 01/2021
3	Inflammation (Inflammations) 01/2019 - 12/2015
2	Lupus Nephritis 02/2022 - 06/2015
2	Disease Progression 01/2022 - 01/2021
2	Ductal Carcinoma 07/2020 - 01/2019
2	Adenocarcinoma 01/2019 - 01/2017
2	Hyperplasia 01/2019 - 04/2015
2	Carcinogenesis 01/2016 - 04/2015
2	Obesity 08/2014 - 05/2009
2	Prostatic Diseases 04/2012 - 08/2009
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2008 - 01/2005
2	Squamous Cell Carcinoma of Head and Neck 01/2008 - 01/2005
1	Primary Graft Dysfunction 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Neuroinflammatory Diseases 05/2021
1	Glycogen Storage Disease (Glycogenosis) 01/2021
1	Heart Failure 01/2021
1	Congenital Disorders of Glycosylation 07/2020
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 04/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Stroke (Strokes) 01/2020
1	Lymphatic Metastasis 05/2019
1	Necrosis 03/2019
1	Atherosclerosis 01/2019
1	Triple Negative Breast Neoplasms 01/2019
1	Fibroadenoma 01/2019
1	Lobular Carcinoma 01/2019
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2018

Drug/Important Bio-Agent (IBA)

30	Polysaccharides (Glycans)IBA 01/2022 - 06/2011
26	Proteins (Proteins, Gene)FDA Link 02/2022 - 01/2004
26	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2004
6	Formaldehyde (Formol)FDA Link 09/2021 - 01/2014
6	Glycoproteins (Glycoprotein)IBA 07/2020 - 02/2009
5	Blood Proteins (Serum Proteins)IBA 05/2009 - 01/2004
4	GlycosphingolipidsIBA 02/2022 - 06/2015
4	CollagenIBA 01/2022 - 01/2019
4	AntigensIBA 01/2021 - 01/2014
4	Peptides (Polypeptides)IBA 01/2021 - 05/2009
4	Prostate-Specific Antigen (Semenogelase)IBA 01/2015 - 02/2009
3	Mannose (D-Mannose)IBA 01/2022 - 01/2019
3	Immunoglobulin G (IgG)IBA 01/2022 - 01/2019
3	ProteomeIBA 01/2021 - 12/2012
3	CarbohydratesIBA 01/2021 - 10/2011
3	Membrane Proteins (Integral Membrane Proteins)IBA 07/2020 - 12/2015
3	SphingosineIBA 12/2015 - 01/2013
3	CeramidesIBA 01/2015 - 01/2013
3	prostatic acid phosphataseIBA 10/2013 - 02/2009
2	Biological ProductsIBA 01/2022 - 01/2019
2	ParaffinIBA 09/2021 - 01/2019
2	AcetylglucosamineIBA 01/2021 - 10/2013
2	EnzymesIBA 01/2021 - 08/2014
2	LectinsIBA 01/2021 - 10/2006
2	polylactosamineIBA 01/2021 - 01/2019
2	CholesterolIBA 01/2020 - 01/2019
2	FucoseIBA 05/2019 - 03/2019
2	Phosphotransferases (Kinase)IBA 12/2015 - 09/2009
2	SphingolipidsIBA 12/2015 - 08/2014
2	Tumor Biomarkers (Tumor Markers)IBA 01/2015 - 10/2013
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 02/2022
1	ElastinIBA 01/2022
1	AutoantibodiesIBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Prostaglandins DIBA 01/2022
1	LipopolysaccharidesIBA 05/2021
1	Uridine Diphosphate (UDP)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Fluvastatin FDA Link 01/2021
1	GlycogenIBA 01/2021
1	N-AcetylglucosaminyltransferasesIBA 01/2021
1	Collagenases (Collagenase)FDA Link 01/2021
1	Mevalonic Acid (Mevalonate)IBA 01/2021
1	EpitopesIBA 01/2021
1	Cadherins (E-Cadherin)IBA 07/2020
1	alpha2 Subunit Collagen Type IIBA 01/2020
1	Fluconazole (Zonal)FDA LinkGeneric 01/2020
1	Proline (L-Proline)FDA Link 01/2020
1	N-acetyllactosamineIBA 05/2019
1	Glycoside Hydrolases (Endoglycosidases)IBA 05/2019
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 03/2019
1	human ERBB2 proteinIBA 01/2019
1	Lysophosphatidic Acid ReceptorsIBA 01/2019
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2019
1	LDL Receptors (LDL Receptor)IBA 01/2019
1	lysophosphatidic acidIBA 01/2018
1	GangliosidesIBA 12/2017

Therapy/Procedure

10	Lasers (Laser) 01/2021 - 01/2004
7	Therapeutics 02/2022 - 11/2002
2	Prostatectomy (Retropubic Prostatectomy) 01/2020 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2013 - 05/2004
1	Segmental Mastectomy (Lumpectomy) 01/2019